NuPathe (PATH)

Latest Trade: $7.91 0.00 (0.0%)

IPO News

NuPathe prices IPO at $10, below the range 8/6/10
NuPathe significantly reduces proposed IPO deal size 8/5/10
Pharmaceutical company NuPathe sets IPO terms and timing 7/21/10
Migraine drug developer NuPathe plans $86 million IPO 5/14/10

Latest User Comments

Post Comment | Read More

Business

Business
Specialty pharma seeking approval for Zelrix, a patch for migraine treatment.
Industry
Health-Drugs
Employees
22
Founded
2005

Performance History

Interested in IPO Investing?

First Day Return
9.6100

-3.9%
Aftermarket Return
9.6100

-17.7%
Return from IPO
10.0000

-20.9%

IPO Date
08/05/10
Offer Price
$10.00
Offer Shares
5.0 mm
Lead Manager(s)
Leerink Swann
Lazard Capital Markets
Co Manager(s)
Stifel Nicolaus Weisel

All Underwriters

PATH Daily

Week

Month

Quarter

1 Year

Chart

Corporate Data

Company Address
227 Washington Street, Suite 200
Conshohocken, PA
Phone Number
(484) 567-0130
Web Address
www.nupathe.com